BioAdaptives(BDPT)
$0.000.00 (0.00%)
BDPT
BioAdaptives financials statements
$0.00
At close:0.00 (0.00%)
BioAdaptives (BDPT) Ratios
25 Followers
BioAdaptives Ratios
BDPT's free cash flow for Q2 2026 was $111.46K. For the 2026 fiscal year, BDPT's free cash flow was increased by $0.00 and operating cash flow was $111.46K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.09 | 0.15 | 0.05 | 0.02 | 0.07 |
| Quick Ratio | 0.07 | 0.14 | 0.04 | 0.02 | 0.07 |
| Cash Ratio | 0.07 | 0.08 | 0.03 | 0.02 | 0.07 |
| Solvency Ratio | -0.66 | -0.52 | -0.39 | -0.56 | -0.74 |
| Operating Cash Flow Ratio | -0.22 | -0.14 | -0.13 | -0.15 | -0.13 |
| Short-Term Operating Cash Flow Coverage | -1.34 | -0.73 | -0.68 | -0.58 | -0.36 |
| Net Current Asset Value | $ -2.14M | $ -1.46M | $ -1.66M | $ -1.45M | $ -1.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.70 | 1.31 | 3.17 | 10.51 | 2.94 |
| Debt-to-Equity Ratio | -0.18 | -0.23 | -0.20 | -0.27 | -0.40 |
| Debt-to-Capital Ratio | -0.22 | -0.31 | -0.25 | -0.37 | -0.67 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.11 | -0.18 | -0.06 | -0.03 | -0.14 |
| Debt Service Coverage Ratio | -3.26 | -1.33 | -1.06 | -0.80 | -0.91 |
| Interest Coverage Ratio | -14.70 | -6.55 | -1.41 | -1.46 | -2.33 |
| Debt to Market Cap | 1.73 | 0.70 | 0.73 | 6.16 | 1.29 |
| Interest Debt Per Share | 0.05 | 0.05 | 0.08 | 0.96 | 3.15 |
| Net Debt to EBITDA | -0.15 | -0.35 | -0.52 | -0.67 | -0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 68.37% | 31.81% | 37.88% | 41.49% | 51.10% |
| EBIT Margin | -8135.56% | -4610.39% | -1925.43% | -3528.18% | -3934.06% |
| EBITDA Margin | -8113.68% | -4595.07% | -1823.91% | -3167.21% | -3256.47% |
| Operating Profit Margin | -5701.79% | -4751.76% | -801.68% | -2456.92% | -3216.02% |
| Pretax Profit Margin | -8523.35% | -7141.53% | -2492.56% | -5216.58% | -5309.47% |
| Net Profit Margin | -8523.35% | -7096.06% | -2492.56% | -5216.58% | -5309.47% |
| Continuous Operations Profit Margin | -8523.35% | -7096.06% | -2492.56% | -5216.58% | -5309.47% |
| Net Income Per EBT | 100.00% | 99.36% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 149.49% | 150.29% | 310.92% | 212.32% | 165.09% |
| Return on Assets (ROA) | -689.64% | -343.28% | -684.63% | -2401.24% | -706.67% |
| Return on Equity (ROE) | 73.14% | 61.41% | 43.24% | 61.73% | 96.06% |
| Return on Capital Employed (ROCE) | 48.93% | 41.12% | 13.91% | 29.07% | 58.19% |
| Return on Invested Capital (ROIC) | 59.70% | 53.66% | 17.38% | 39.83% | 96.92% |
| Return on Tangible Assets | -689.64% | -343.28% | -804.00% | -2610.42% | -1181.42% |
| Earnings Yield | -699.85% | -182.38% | -158.97% | -1408.67% | -311.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 4.52 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.43 | 1.44 | 5.41 | 1.45 | 5.53 |
| Inventory Turnover | 0.13 | 0.45 | 1.16 | 0.00 | 2.04 |
| Fixed Asset Turnover | 1.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.08 | 0.05 | 0.27 | 0.46 | 0.13 |
| Working Capital Turnover Ratio | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 |
| Cash Conversion Cycle | 1969.46 | 634.82 | 246.78 | -252.01 | 113.23 |
| Days of Sales Outstanding | 0.00 | 80.67 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 2822.64 | 807.61 | 314.30 | 0.00 | 179.27 |
| Days of Payables Outstanding | 853.18 | 253.46 | 67.52 | 252.01 | 66.05 |
| Operating Cycle | 2822.64 | 888.28 | 314.30 | 0.00 | 179.27 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -0.03 | -0.04 | -0.32 | -0.71 |
| Free Cash Flow Per Share | -0.05 | -0.03 | -0.04 | -0.32 | -0.71 |
| Dividend Paid and CapEx Coverage Ratio | -28.67 | -83172.33 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -28.67 | -83172.33 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.34 | -0.73 | -0.68 | -0.58 | -0.36 |
| Operating Cash Flow to Sales Ratio | -28.23 | -19.70 | -7.83 | -13.23 | -8.02 |
| Free Cash Flow Yield | -239.90% | -50.62% | -49.96% | -357.29% | -47.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.15 | -0.55 | -0.63 | -0.07 | -0.32 |
| Price-to-Sales (P/S) Ratio | 12.18 | 38.91 | 15.68 | 3.70 | 17.06 |
| Price-to-Book (P/B) Ratio | -0.10 | -0.34 | -0.27 | -0.04 | -0.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.42 | -1.98 | -2.00 | -0.28 | -2.13 |
| Price-to-Operating Cash Flow Ratio | -0.43 | -1.98 | -2.00 | -0.28 | -2.13 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.07 | 0.01 | 0.00 | 0.01 |
| Enterprise Value Multiple | -0.30 | -1.20 | -1.37 | -0.79 | -1.07 |
| Enterprise Value | 448.59K | 698.55K | 716.28K | 430.24K | 691.32K |
| EV to EBITDA | -0.30 | -1.20 | -1.37 | -0.79 | -1.07 |
| EV to Sales | 24.54 | 55.14 | 25.08 | 25.05 | 34.96 |
| EV to Free Cash Flow | -0.84 | -2.80 | -3.20 | -1.89 | -4.36 |
| EV to Operating Cash Flow | -0.87 | -2.80 | -3.20 | -1.89 | -4.36 |
| Tangible Book Value Per Share | -0.21 | -0.18 | -0.28 | -2.06 | -5.12 |
| Shareholders’ Equity Per Share | -0.21 | -0.18 | -0.28 | -2.05 | -4.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.02 | 0.09 |
| Net Income Per Share | -0.15 | -0.11 | -0.12 | -1.27 | -4.67 |
| Tax Burden | 1.00 | 0.99 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.05 | 1.55 | 1.29 | 1.48 | 1.35 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 57.48 | 39.85 | 7.41 | 21.36 | 17.62 |
| Stock-Based Compensation to Revenue | 24.27 | 16.49 | 0.00 | 0.00 | 8.29 |
| Income Quality | 0.33 | 0.28 | 0.31 | 0.25 | 0.15 |
Currency in USD
